Fab preparations of sheep polyclonal anti-digoxin Abs have proven useful fo
r reversal of the toxic effects of digoxin overdoses in patients. Unfortuna
tely, the use of foreign species proteins in humans is limited because of t
he potential for immunological responses that include hypersensitivity reac
tions and acute anaphylaxis, Immunization of recently developed transgenic
mice, whose endogenous mu heavy and kappa light chain Ig genes are inactiva
ted and which carry human Ig gene segments, with a digoxin-protein conjugat
e has enabled us to generate and isolate eight hybridoma cell lines secreti
ng human sequence anti-digoxin mAbs, Six of the mAbs have been partially ch
aracterized and shown to have high specificity and low nanomolar affinities
for digoxin, In addition, detailed competition binding studies performed w
ith three of these mAbs have shown them to have distinct differences in the
ir digoxin binding, and that all three structural moieties of the drug, the
primary digitoxose sugar, steroid, and five-member unsaturated lactone rin
g, contribute to Ab recognition.